Page last updated: 2024-08-25

voriconazole and Neutropenia

voriconazole has been researched along with Neutropenia in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.78)	18.2507
2000's	53 (49.07)	29.6817
2010's	44 (40.74)	24.3611
2020's	8 (7.41)	2.80

Authors

Authors	Studies
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Haastrup, EK; Hare, RK; Helweg-Larsen, J; Overgaard, UM; Risum, M; Rubek, N	1
Liu, A; Sun, C; Xiang, Y; Yuan, Y; Zhao, L	1
Abdollahzadeh, H; Aghebati-Maleki, A; Aghebati-Maleki, L; Hasani, A; Hassanpour, P; Morovati, H; Nami, S; Raeisi, M; Rezaee, MA; Spotin, A	1
Abbas-Aghababazadeh, F; Caceres, G; Fridley, BL; Greene, JN; Hicks, JK; Kelly, K; Komrokji, RS; Kubal, TE; Lancet, JE; McLeod, HL; Pasikhova, Y; Qin, D; Quilitz, RE; Salchert, YS; Shahbazian, K; So, W; Velez, AP	1
Fukuhara, N; Harigae, H; Ichikawa, S; Okitsu, Y; Onishi, Y; Onodera, K; Watanabe, S	1
Moncada, D; Ramírez, I	1
Choi, S; Choi, SH; Chong, YP; Jung, J; Kim, MJ; Kim, SH; Kim, YS; Lee, SO; Son, HJ; Song, JS; Woo, JH	1
Hisaka, A; Hozuki, S; Sato, H; Shibata, Y; Singh, SP; Tamemoto, Y; Yoshitomo, A	1
Baker, CJ; Brackett, J; Edwards, MS; Foster, CE; Healy, CM; Schady, DA	1
Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A	1
Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Hope, W; Kontoyiannis, DP; Lademacher, C; Lortholary, O; Mullane, K; Patterson, TF; Selleslag, D	1
Benedetti, E; Campani, D; Di Candio, G; Di Franco, G; Furbetta, N; Guadagni, S; Morelli, L; Mosca, F; Palmeri, M; Petrini, M; Pieroni, E; Tagliaferri, E	1
Chauhan, V; Córdoba, R; de Jong, J; De Wilde, S; de Zwart, L; Hellemans, P; Jiao, J; Manikhas, G; Masterson, T; Myasnikov, A; Osmanov, D; Ouellet, D; Panizo, C; Patricia, D; Snoeys, J; Sukbuntherng, J	1
Díaz, MC; Luppi, M; Olivares, R	1
Dehghan Manshadi, SA; Giasvand, F; Jahanbin, B; Khodaveisi, S; Safai Nodeh, SR; Salehi, M; Seifi, A	1
Ackerman, MJ; Barreto, JN; Cullen, MW; Dahl, NJ; Dierkhising, RA; Grove, ME; Mara, KC; Patnaik, MM; Sierzchulski, AG; Tosh, PK	1
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC	1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z	1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M	1
Gamaletsou, MN; Walsh, TJ	1
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ	1
Barutcu, E; Celik, AD; Pamuk, GE; Pamuk, ON	1
Daphtary, M; Dumitriu, B; Rios, O; Scheinberg, P; Townsley, D; Weinstein, B; Wu, CO; Young, NS	1
Bashoura, L; Faiz, SA; Grosu, HB; Ordonez, NG; Ost, D	1
Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Murata, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Tanihara, A; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R	1
Choi, SH; Hong, HL; Jung, J; Kim, SH; Kim, YS; Lee, SO; Woo, JH	1
Block, C; Moses, AE; Or, R; Shapira, MY; Strahilevitz, J; Tzadok, R	1
Balla, A; Gibson, P; Greene, L; Hugh, J; Pierson, J; Wojewoda, C	1
Capilla, J; Guarro, J; Mayayo, E; Paredes, K	1
Bergami, E; Cavanna, C; Decembrino, N; Introzzi, F; Lallitto, F; Mangione, F; Marone, P; Tamarozzi, F; Tortorano, AM; Zecca, M	1
Jiang, M; Li, Y; Liang, X; Liu, J; Nong, G	1
Kimura, S	1
Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K	1
Aurbach, U; Cornely, OA; De Hoog, S; Demeter, J; Durán Graeff, L; Hamprecht, A; Kindo, A; Racil, Z; Seidel, D; Vehreschild, MJ; Wisplinghoff, H; Ziegler, M	1
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K	2
Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA	1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W	1
Maschmeyer, G	1
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J	1
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A	1
Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M	1
Wingard, J	1
Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B	1
Corey, M	1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS	1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A	1
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H	1
Azim, S; Fadoo, Z; Manzoor, NF	1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC	1
Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M	1
Caira, M; Fianchi, L; Pagano, L; Valentini, CG	1
Kurokawa, M; Masamoto, Y; Nannya, Y	1
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M	1
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L	1
Egerer, G	1
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G	1
Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T	1
Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM	1
Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V	1
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L	1
Andes, D; Conklin, R; Marchillo, K; Stamstad, T	1
Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD	1
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C	1
Sims-McCallum, RP	1
Höhl, R	1
Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M	1
Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK	1
Gavaldá, J; Lumbreras, C	1
Klastersky, J	1
Aebi, C; Aebischer, CC; Ammann, RA; Gugger, M; Jaton, K; Ritz, N; Schmid, RA	1
Danaher, PJ	1
Lowry, CM; Marty, FM	1
Oren, I	1
Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD	1
Chan-Tack, KM	1
Colombo, GL; Morlotti, L; Serra, G	1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G	1
Chamilos, G; Kontoyiannis, DP	1
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ	1
Dombrowski, F; Franke, A; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M; Schalk, E	1
Colson, YL; Marty, FM; Paul, S	1
Klastersky, J; Paesmans, M	1
Aperis, G; Mylonakis, E; Spanakis, EK	1
Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA	1
Collins, CD; DePestel, DD; Stevenson, JG; Stuntebeck, ER	1
Ho, DY; Lee, JD; Montoya, JG; Rosso, F	1
Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K	1
Collins, CD; DePestel, DD; Erba, HP; Mackler, ER; Shehab, N; Welch, K	1
Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C	1
Bongiovanni, M; Chalandon, Y; Meyer, M; Pache, JC; Van Delden, C; Waldvogel, S	1
Jarque, I; Sanz, MA	1
Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S	1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA	1
Buadi, FK; McClune, B; Przepiorka, D	1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J	1
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O	1
Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H	1
Hoban, DJ; Karlowsky, JA; Zhanel, GG	1
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S	1
Marr, KA	1
Dixon, CA; Goldberger, MJ; Powers, JH	1
De Roux, A; Grassot, A; Grysczyk, H; Lode, H; Mauch, H	1
Dismukes, WE; Lee, J; Walsh, TJ	1
Johnson, JR	1
Apisarnthanarak, A; Little, JR; Tebas, P	1
Cornely, OA; Heussel, CP; Ullmann, AJ	1

Reviews

21 review(s) available for voriconazole and Neutropenia

Article	Year
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp. Mycopathologia, 2020, Volume: 185, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole	2020
Trichosporonosis in Pediatric Patients With a Hematologic Disorder. Journal of the Pediatric Infectious Diseases Society, 2018, Aug-17, Volume: 7, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporonosis; Voriconazole	2018
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature. Infection, 2018, Volume: 46, Issue:3 Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Intestinal Perforation; Intestine, Small; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Neutropenia; Treatment Outcome; Voriconazole	2018
Treatment of fungal disease in the setting of neutropenia. Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013 Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2014
Invasive Aspergillosis in Hematological Patients. Medical mycology journal, 2016, Volume: 57, Issue:2 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Biomarkers; Echinocandins; Hematologic Neoplasms; Humans; Neutropenia; Opportunistic Infections; Risk Factors; Stem Cell Transplantation; Tomography, X-Ray Computed; Voriconazole	2016
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections. The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1 Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole	2009
Modern antifungal therapy for neutropenic fever. Current hematologic malignancy reports, 2006, Volume: 1, Issue:2 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2006
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review. Medical mycology, 2011, Volume: 49, Issue:8 Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole	2011
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2011
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:12 Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole	2002
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients]. Mycoses, 2003, Volume: 46 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2003
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia]. Medicina clinica, 2004, May-01, Volume: 122, Issue:16 Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2004
[Invasive aspergillosis: clinical manifestations and treatment]. Revista iberoamericana de micologia, 2003, Volume: 20, Issue:3 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole	2003
Voriconazole versus amphotericin B in cancer patients with neutropenia. The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole	2006
Zygomycoses in patients with acute leukaemia. Annals of hematology, 2006, Volume: 85, Issue:5 Topics: Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole; Zygomycosis	2006
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:2 Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
Treating disseminated fusariosis: amphotericin B, voriconazole or both? Mycoses, 2007, Volume: 50, Issue:3 Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature. Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:8 Topics: Acute Disease; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fever; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2007
[Current indications for voriconazole in onco-hematological patients]. Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3 Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis	2007

Trials

11 trial(s) available for voriconazole and Neutropenia

Article	Year
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3 Topics: Adult; Aged; Antifungal Agents; Aspergillus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neutropenia; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2018
A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. Leukemia & lymphoma, 2018, Volume: 59, Issue:12 Topics: Adenine; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Erythromycin; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Piperidines; Polymorphism, Single Nucleotide; Pyrazoles; Pyrimidines; Voriconazole	2018
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia. Leukemia & lymphoma, 2019, Volume: 60, Issue:14 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia; Long QT Syndrome; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Voriconazole	2019
Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution. Blood, 2014, Oct-30, Volume: 124, Issue:18 Topics: Anemia, Aplastic; Child; Clone Cells; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Neutropenia; Recurrence; Survival Rate; Voriconazole	2014
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1 Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. European journal of haematology, 2010, Volume: 84, Issue:3 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult	2010
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole	2011
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia. Mycoses, 2012, Volume: 55, Issue:3 Topics: Antifungal Agents; Australia; Caspofungin; Echinocandins; Economics, Pharmaceutical; Fever; Humans; Lipopeptides; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2012
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole	2013
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia, 2008, Volume: 22, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2008
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2002

Other Studies

76 other study(ies) available for voriconazole and Neutropenia

Article	Year
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
Disseminated fusariosis with cerebral involvement in a patient with acute myeloid leukemia: Successful outcome with intrathecal -and systemic antifungal treatment. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:9 Topics: Antifungal Agents; Female; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Neutropenia; Voriconazole	2022
Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records. Pharmacoepidemiology and drug safety, 2023, Volume: 32, Issue:4 Topics: Acyclovir; Aged; Agranulocytosis; Electronic Health Records; Ganciclovir; Humans; Meropenem; Neutropenia; Palonosetron; Thrombocytopenia; Vancomycin; Voriconazole	2023
Molecular diagnosis, phylogenetic analysis, and antifungal susceptibility profiles of Candida species isolated from neutropenic oncological patients. BMC infectious diseases, 2023, Nov-06, Volume: 23, Issue:1 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Phylogeny; Voriconazole	2023
Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Risk Management; Voriconazole; Young Adult	2020
Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; Cord Blood Stem Cell Transplantation; Endophthalmitis; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Treatment Outcome; Vitrectomy; Voriconazole	2020
Risk factors for mortality in patients with pulmonary mucormycosis. Mycoses, 2020, Volume: 63, Issue:7 Topics: Aged; Antifungal Agents; Female; Hospital Mortality; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Neutropenia; Pneumonia; Retrospective Studies; Risk Factors; Seoul; Tertiary Care Centers; Voriconazole	2020
Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6. Drug metabolism and pharmacokinetics, 2021, Volume: 39 Topics: Alopecia; Animals; Cyclophosphamide; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Humans; Mice; Neutropenia; Prognosis; Risk Assessment; Voriconazole	2021
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study. Mycoses, 2018, Volume: 61, Issue:3 Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2018
[Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2018, Volume: 35, Issue:4 Topics: Adolescent; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fusariosis; Humans; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole	2018
Invasive fungal consecutive infections in a patient with acute myeloid leukaemia. Nigerian journal of clinical practice, 2019, Volume: 22, Issue:4 Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Female; Fever; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mucormycosis; Neutropenia; Treatment Outcome; Voriconazole	2019
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole. American journal of hematology, 2013, Volume: 88, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole	2013
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient]. Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2 Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species. Mycopathologia, 2014, Volume: 177, Issue:1-2 Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole	2014
The development of pulmonary aspergillosis and pneumothorax in a patient with neutropenic systemic lupus erythematosus and successful treatment of the first case. BMJ case reports, 2014, May-21, Volume: 2014 Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Drainage; Female; Humans; Lupus Erythematosus, Systemic; Neutropenia; Opportunistic Infections; Pneumothorax; Prednisolone; Pulmonary Aspergillosis; Staphylococcal Infections; Staphylococcus aureus; Voriconazole; Young Adult	2014
Critical airway obstruction due to pseudomembranous Aspergillus tracheitis. American journal of respiratory and critical care medicine, 2014, Dec-01, Volume: 190, Issue:11 Topics: Acute Disease; Adult; Airway Obstruction; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus; Bronchoscopy; Cryotherapy; Dyspnea; Female; Humans; Immunocompromised Host; Leukemia; Necrosis; Neutropenia; Radiography, Thoracic; Steroids; Tracheitis; Voriconazole	2014
Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:5 Topics: Antifungal Agents; Chemoprevention; Clinical Trials as Topic; Cost-Benefit Analysis; Diagnostic Tests, Routine; Echinocandins; Hematologic Diseases; Humans; Lipopeptides; Micafungin; Mycoses; Neutropenia; Retrospective Studies; Voriconazole	2015
Immune reconstitution inflammatory syndrome in neutropenic patients with invasive pulmonary aspergillosis. The Journal of infection, 2015, Volume: 70, Issue:6 Topics: Antifungal Agents; Female; Galactose; Humans; Immune Reconstitution Inflammatory Syndrome; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Middle Aged; Neutropenia; Republic of Korea; Retrospective Studies; Voriconazole	2015
Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution. Mycoses, 2015, Volume: 58, Issue:12 Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Clinical Protocols; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pharmaceutical Solutions; Survival Rate; Transplantation, Homologous; Voriconazole; Young Adult	2015
Disseminated cutaneous Curvularia infection in an immunocompromised host; diagnostic challenges and experience with voriconazole. Journal of cutaneous pathology, 2016, Volume: 43, Issue:4 Topics: Adult; Ascomycota; Dermatomycoses; Female; Humans; Immunocompromised Host; Neutropenia; Voriconazole	2016
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole	2016
Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia. The new microbiologica, 2016, Volume: 39, Issue:1 Topics: Acute Disease; Acyclovir; Amphotericin B; Antifungal Agents; Appendicitis; Aspergillosis; Aspergillus; Child; Ciprofloxacin; Fluconazole; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Voriconazole	2016
[Clinical analysis of 16 cases of invasive pulmonary aspergillosis in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2016, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Aspergillosis; Child; Cough; Female; Fever; Galactose; Glucocorticoids; Humans; Male; Mannans; Measles; Neutropenia; Retrospective Studies; Risk Factors; Sputum; Voriconazole	2016
Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Invasive Fungal Infections; Japan; Leukemia, Myeloid, Acute; Male; Neutropenia; Pneumonia, Bacterial; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole; Young Adult	2018
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry. Mycoses, 2017, Volume: 60, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fungemia; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Registries; Saccharomycetales; Voriconazole; Young Adult	2017
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1 Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2009
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole	2009
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole	2009
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection. International journal of antimicrobial agents, 2010, Volume: 35, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2010
Antifungal management. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:3 Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole	2010
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties. Mycopathologia, 2010, Volume: 170, Issue:3 Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2010
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy. Pediatric hematology and oncology, 2010, Volume: 27, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone marrow transplantation, 2011, Volume: 46, Issue:5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2011
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients. International journal of hematology, 2011, Volume: 93, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole	2011
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2). JPMA. The Journal of the Pakistan Medical Association, 2010, Volume: 60, Issue:11 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2010
Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1 Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2011
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1 Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole	2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay. Medical mycology, 2011, Volume: 49, Issue:8 Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole	2011
[Ambulatory therapy of aspergillosis in hematological and oncological patients]. Mycoses, 2012, Volume: 55 Suppl 2 Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole	2012
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole	2013
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jul-15, Volume: 37, Issue:2 Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11 Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2003
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10 Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2003
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection. The Pediatric infectious disease journal, 2003, Volume: 22, Issue:11 Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole	2003
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12 Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole	2003
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2003
Alternatives to amphotericin B for Candida rugosa infection. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole	2004
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical? The New England journal of medicine, 2004, Sep-30, Volume: 351, Issue:14 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. European journal of pediatrics, 2005, Volume: 164, Issue:4 Topics: Absidia; Antifungal Agents; Child; Drug Resistance, Fungal; Female; Humans; Neutropenia; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole; Zygomycosis	2005
Caspofungin versus liposomal amphotericin B for empirical therapy. The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Caspofungin versus liposomal amphotericin B for empirical therapy. The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole	2005
Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Mar-01, Volume: 40, Issue:5 Topics: Aged; Antifungal Agents; Fever; Humans; Mucormycosis; Neutropenia; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2005
[Disseminated fusarium infection in two neutropenic children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:7 Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2005
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia. Southern medical journal, 2005, Volume: 98, Issue:9 Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts	2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole]. Recenti progressi in medicina, 2005, Volume: 96, Issue:9 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica, 2005, Volume: 90 Suppl Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole	2005
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. The Journal of infection, 2005, Volume: 51, Issue:4 Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole	2005
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. The Annals of thoracic surgery, 2006, Volume: 82, Issue:1 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis	2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole	2006
Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia. Clinical drug investigation, 2007, Volume: 27, Issue:4 Topics: Amphotericin B; Antifungal Agents; Decision Support Techniques; Economics, Pharmaceutical; Fever; Health Care Costs; Humans; Liposomes; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2007
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2007
Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia. Pharmacotherapy, 2007, Volume: 27, Issue:7 Topics: Amphotericin B; Antifungal Agents; Female; Fever; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study. BMC infectious diseases, 2007, Jul-02, Volume: 7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2007
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature. Mycoses, 2008, Volume: 51, Issue:1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole	2008
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia. Pharmacotherapy, 2008, Volume: 28, Issue:1 Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10 Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole	2008
[Rare pulmonary mycoses in patients with hematologic diseases]. Revue de pneumologie clinique, 1998, Volume: 54, Issue:5 Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole	1998
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model. Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole	1999
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6 Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole	1999
Empirical antifungal therapy--new options, new tradeoffs. The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4 Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2002
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4 Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole	2002
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia]. Deutsche medizinische Wochenschrift (1946), 2002, Mar-08, Volume: 127, Issue:10 Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Male; Middle Aged; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2002
Decisions about voriconazole versus liposomal amphotericin B. The New England journal of medicine, 2002, May-09, Volume: 346, Issue:19 Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole	2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy. The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22 Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy. The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22 Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fever; Humans; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy. The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22 Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole	2002